Characterizing the next generation of bioconjugates
Thursday, November 12 at 16:00 GMT | 17:00 CET | 11:00 EST | 08:00 PST
Join leading voices from across the biopharmaceutical industry as they discuss the analytical and bioanalytical challenges shaping the next generation of bioconjugate therapeutics.
As the field expands beyond traditional antibody-drug conjugates (ADCs) to include increasingly complex modalities, such as antibody-oligonucleotide conjugates (AOCs), bispecific ADCs, and dual-payload constructs, development teams need a more integrated understanding of molecular attributes, product heterogeneity, stability, and behavior in biological systems.
In this SelectScience® Accelerating Science Forum, experts from across the development pathway will explore how characterization and bioanalytical strategies are evolving in response to this complexity. The panel will consider how CMC, PK, and bioanalytical evidence can be connected to support informed decisions from molecular design and early development through manufacturing.
Attend this online roundtable discussion to:
- Explore how next-generation bioconjugate formats are changing analytical and bioanalytical requirements
- Gain insights into evaluating critical quality attributes, heterogeneity, stability, and clinically relevant species
- Understand how CMC, PK, and bioanalytical evidence can inform development and manufacturing decisions
- Hear expert perspectives on the capabilities needed to support future bioconjugate modalities
Certificate of attendance
If you attend the live event, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand recording, you can request a certificate of attendance by emailing editor@selectscience.net.
Forum details
- Cost: Free to attend
- Location: Online
- Duration: 60 mins
Registration is required to access this Accelerating Science Forum. If you missed the live broadcast, register now to watch the recording.
Have a question about our online events? Contact us here.
Speakers
What will this webinar cover?
- Understand how emerging bioconjugate formats are changing analytical and bioanalytical requirements
- Explore the challenges of evaluating product quality, heterogeneity, stability, and clinically relevant species
- Learn how CMC, PK, and bioanalytical evidence can inform molecular design and development decisions
- Consider the capabilities and cross-functional approaches needed to support future bioconjugate modalities